These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 9931388

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma.
    Bramhall SR, Neoptolemos JP, Stamp GW, Lemoine NR.
    J Pathol; 1997 Jul; 182(3):347-55. PubMed ID: 9349239
    [Abstract] [Full Text] [Related]

  • 10. Complex roles of tissue inhibitors of metalloproteinases in cancer.
    Jiang Y, Goldberg ID, Shi YE.
    Oncogene; 2002 Mar 28; 21(14):2245-52. PubMed ID: 11948407
    [Abstract] [Full Text] [Related]

  • 11. Role of matrix metalloproteinases and their inhibitors in pancreatic cancer.
    Evans JD, Ghaneh P, Kawesha A, Neoptolemos JP.
    Digestion; 1997 Mar 28; 58(6):520-8. PubMed ID: 9438596
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A phase II trial of marimastat in advanced pancreatic cancer.
    Evans JD, Stark A, Johnson CD, Daniel F, Carmichael J, Buckels J, Imrie CW, Brown P, Neoptolemos JP.
    Br J Cancer; 2001 Dec 14; 85(12):1865-70. PubMed ID: 11747327
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Matrix metalloproteinase inhibitors: present achievements and future prospects.
    Denis LJ, Verweij J.
    Invest New Drugs; 1997 Dec 14; 15(3):175-85. PubMed ID: 9387040
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tissue inhibitors of matrix metalloproteinases in cancer.
    Blavier L, Henriet P, Imren S, Declerck YA.
    Ann N Y Acad Sci; 1999 Jun 30; 878():108-19. PubMed ID: 10415723
    [Abstract] [Full Text] [Related]

  • 20. [Current data on metalloproteinases, obligatory partners of tumor progression].
    Rémy L.
    Pathol Biol (Paris); 1997 Nov 30; 45(9):759-65. PubMed ID: 9538475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.